• 1
    American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002;159(suppl. 4):150.
  • 2
    Goodwin GM, Young AH. The British Association for Psychopharmacology guidelines for treatment of bipolar disorder: a summary. J Psychopharmacol 2003;17(suppl. 4):36.
  • 3
    Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987;144:14031411.
  • 4
    Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994;164:549550.
  • 5
    Henry C, Demotes-Mainard J. Avoiding drug-induced switching in patients with bipolar depression. Drug Saf 2003;26:337351.
  • 6
    Möller HJ, Grunze H. Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur Arch Psychiatry Clin Neurosci 2000;250:5768.
  • 7
    Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: a systematic review of randomised controlled trials. Am J Psychiatry 2004;161:15371547.
  • 8
    Visser HM, Van Der Mast R. Bipolar disorder, antidepressants and induction of hypomania or mania. A systematic review. World J Biol Psychiatry 2005;6:231241.
  • 9
    Hill AB. The environment and disease: association or causation. Proc R Soc Med 1965;58:295300.
  • 10
    Möller HJ, Grunze H, Broich K. Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than anttidepressants are the treatment of choice? Eur Arch Psychiatry Clin Neurosci 2006;256:116.
  • 11
    Sachs GS, Nierenberg AA, Calabrese JR et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007;356:17111722.
  • 12
    Baillarger J. De la folie à double forme. Ann Med Psychol 1854;6:369384.
  • 13
    Pichot P. The birth of the bipolar disorder. Eur Psychiatry 1995;10:110.
  • 14
    Ball M, Doutrebente M. Folie à double forme continue. Ann Med Psychol 1880;2:192200.
  • 15
    Ballet G. Folie périodique. In: BouchardC-J, BrissaudE, eds. Traité de médecine. Paris: G. Masson, 1894:11221134.
  • 16
    Angst J. Switch from depression to mania – a record study over decades between 1920 and 1982. Psychopathology 1985;18:140154.
  • 17
    Angst J, Angst K, Graf-Nold A. Switch rates from depression to mania from 1900–1980. XVIth C.I.N.P Congress, Munich, 1988: Psychopharmacology 1988;96(suppl.1):62 (Abstract).
  • 18
    Bunney WE. Psychopharmacology of the switch process in affective illness. In: LiptonMA, DimascioA, KillamKF, eds. Psychopharmacology: a generation of progress. New York: Raven Press, 1978:12491259.
  • 19
    Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995;152:11301138.
  • 20
    Akiskal HS, Walker PW, Puzantian VR, King D, Rosenthal TL, Dranon M. Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors. J Affect Disord 1983;5:115128.
  • 21
    Keck PE, Corya SA, Altshuler LL et al. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression. J Clin Psychiatry 2005;66:611616.
  • 22
    Angst J, Gamma A, Sellaro R, Lavori P, Zhang H. Recurrence of bipolar disorders and major depression. A life-long perspective. Eur Arch Psychiatry Clin Neurosci 2003;253:236240.
  • 23
    Danish University Antidepressant Group. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 1990;18:289299.
  • 24
    Post RM, Altshuler LL, Leverich GS et al. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry 2006;189:124131.
  • 25
    Vieta E, Martinez-Aran A, Goikolea JM et al. A randomized trial comparing Paroxetine and Venlafaxine in the treatment of bipolar derpressed patients taking mood stabilizers. J Clin Psychiatry 2002;63:508512.
  • 26
    Prien RF, Klett CJ, Caffey EM. Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiatry 1973;29:420425.
  • 27
    Prien RF, Kupfer DJ, Mansky PA et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 1984;41:10961104.
  • 28
    Quitkin FM, Kane J, Rifkin A, Ramos-Lorenzi J, Nayak DV. Prophylactic lithium carbonate with and without imipramine for bipolar I patients: a double-blind study. Arch Gen Psychiatry 1981;38:902907.
  • 29
    Altshuler LL, Suppes T, Black DO et al. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. Am J Psychiatry 2006;163:313315.
  • 30
    Amsterdam JD, Shults J, Brunswick DJ, Hundert M. Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression – low manic switch rate. Bipolar Disord 2004;6:7581.
  • 31
    Simpson SG, DePaulo JR. Fluoxetine treatment of bipolar II depression. J Clin Psychopharmacol 1991;11:5254.
  • 32
    Cohn JB, Collins G, Ashbrook E, Wernicke JF. A comparison of fluoxetine, imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989;4:313322.
  • 33
    Ploog D. “Psychiatrische Gegenregulation” dargestellt am Verlaufe von Elektroschockbehandlungen. Arch Psychiatr Z Neurol 1950;183:617663.
  • 34
    Fink M, Kahn RL, Oaks G. Behavioral patterns in convulsive therapy. Arch Gen Psychiatry 1961;5:3036.
  • 35
    Dunner DL, Fieve RR. Clinical factors in lithium prophylactic failure. Arch Gen Psychiatry 1974;30:229233.
  • 36
    Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry 2000;61:804808.
  • 37
    Coryell W, Solomon D, Turvey C et al. The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry 2003;60:914920.
  • 38
    Coryell W, Endicott J, Keller M. Rapidly cycling affective disorder. Demographics, family history, and course. Arch Gen Psychiatry 1992;49:126131.
  • 39
    Kupka RW, Luckenbaugh DA, Post RM, Leverich GS, Nolen WA. Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. J Clin Psychiatry 2003;64:14831494.
  • 40
    Bauer M, Grof P, Gyulai L, Rasgon N, Glenn T, Whybrow PC. Using technology to improve longitudinal studies: self-reporting with ChronoRecord in bipolar disorder. Bipolar Disord 2004;6:6774.
  • 41
    Bauer M, Rasgon N, Grof P et al. Do antidepressants influence mood patterns? A naturalistic study in bipolar disorder Eur Psychiatry 2006;21:262269.
  • 42
    Angst J, Gamma A. A NRE bipolar spectrum concept: a brief review. Bipolar Disord 2002;4(suppl. 1):S11S14.
  • 43
    Post RM, Roy-Byrne PP, Uhde TW. Graphic representation of the life course of illness in patients with affective disorder. Am J Psychiatry 1988;145:844848.
  • 44
    Leverich GS, Post RM. Life charting the course of bipolar disorder. Curr Rev Mood Anxiety Disord 1996;1:4861.